MA SONGJIANG (President) sold 0.1% of their position (4K shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $44.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/22/2025ACC: 0001140361-25-020156
DirectorOfficer· President
Since Oct 2023
-4K
Net shares
Net seller
$44.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2K
Price / share
$11.25
Trade value
$22.50K
% of position
0.1%
5/20/2025
2.81M→2.81M
Common Stock
Indirect
Shares
−2K
Price / share
$10.83
Trade value
$21.66K
% of position
0.1%
5/21/2025
2.81M→2.81M
Total
Net shares
−4K
Net value
-$44.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/20/2025 | S · Sale | −2K | $11.25 | $22.50K | 0.1% | 2.81M | 2.81M |
| Common Stock Indirect | 5/21/2025 | S · Sale | −2K | $10.83 | $21.66K | 0.1% | 2.81M | 2.81M |
| Total | −4K | -$44.16K | ||||||
Derivative Transactions0
No derivative transactions reported